Introduction urgency, weak stream, hesitancy and nocturia [2] , while it has been shown that men with LUTS experience a Increasingly, questionnaires are being used to assess symptoms and the impact on quality of life of men with much wider range of symptoms, some of which are considerably more troublesome than those included in LUTS related to benign prostatic disease, e.g. the AUA symptom score [1] , IPSS [2] , DAN-PSS-1 [3] , Maine the IPSS [3, 5, 10] . Recently, data indicating that the DAN-PSS may be more sensitive to outcome have been Medical Assessment Program [4] , ICSmale questionnaire [5] , Bolognese Questionnaire [6] , BPH-HRQOL measure published [11] . The ICSmale questionnaire is a wide-ranging question- [7] , BPH Impact Index [8] and ICSQoL questionnaire [9] . The most widely used measure, the IPSS, is now used naire including 20 symptom questions in total, most of which also have a sub-question attached concerning the commonly in randomized trials and other evaluative studies to assess outcome, particularly symptom degree of problem caused. Thus far, the ICSmale questionnaire has been shown to be psychometrically valid and improvement after intervention. However, there are concerns that the IPSS only encompasses some aspects of reliable at baseline [5] . However, it is important that questionnaires used to assess outcome are evaluated outcome. In particular, it contains only seven symptoms, to ensure that they are appropriately responsive to changes over time or after interventions. The ICSmale Results were excluded if they had significant urological disease (e.g. prostate cancer), neurological disease, had underICSmale questionnaire data were available for 355 gone previous prostatic surgery, or were taking medipatients followed after their initial recruitment from the cation active on the lower urinary tract. Each patient following countries; Table 1 shows the numbers and underwent a physical examination, uroflowmetry and proportions of patients followed. As only a proportion of pressure-flow studies, and completed the ICS-'BPH' study patients was followed, it was important to examine questionnaire which includes the ICSmale questionnaire whether they were diCerent from the baseline group [10] . Results concerning the psychometric validity and according to age and symptom levels. The proportions reliability of the ICSmale questionnaire at baseline have in each of the 10-year age bands were very similar for been reported elsewhere [5] .
the follow-up group compared with the original Fifteen centres in nine countries agreed to participate ICS-'BPH' study baseline sample: 24% in those in Phase II of the study. Patients proceeded to treatment <60 years at follow-up, compared with 21% at baseline, according to normal clinical practice and clinicians were 41% compared with 43% for the 60-69 years group, asked to follow patients up #12 months after the and 35% compared with 36% for those >70 years. The baseline evaluation; 422 patients in total were followedfollowed patients were also very similar to the full up in Phase II of the ICS-'BPH' study, 355 of whom baseline sample in terms of their levels of 'any mention completed the ICSmale questionnaire in full (84%).
of a symptom'; eight symptoms were diCerent by either
Evaluating the responsiveness of the ICSmale questionnaire naire does not produce a simple score and so responsiveIsrael 10 10 (100) ness of each question was examined by comparing baseline and follow-up symptom levels for each of the *Includes 13 patients too late to be included in the original ICS-'BPH' study baseline dataset.
major treatment groups. of statistical significance (P<0.0001), i.e. nocturia, urgency, hesitancy, reduced stream and incomplete emp-0 or 1%, and nine by 2-4%. Only incomplete emptying varied by more than this, i.e. 81% in the baseline sample tying, with five more (bladder pain, strain to continue, intermittency, post-void dribble and repeated urination) compared with 75% in the follow-up group.
Patients were followed for a mean of 16 months after significantly better (P<0.0025). For those undergoing watchful waiting, no LUTS were significantly diCerent baseline (range 2-44). Of the 355 men followed, 115 (32%) underwent TURP, 101 (29%) drug treatment, 72 between baseline and follow-up (Fig. 1) . All symptoms reaching statistical significance showed (20%) watchful waiting, 33 (9%) a minimally invasive therapy (including 11 microwave, nine laser, 13 transuran improvement between baseline and follow-up, with the proportion of men improving being considerably ethral incision) and 34 (10%) some other procedure, including 10 an open prostatectomy. Follow-up times higher for those undergoing TURP than other treatments. Table 3 shows the percentage change in 'any were statistically significantly diCerent between the treatment groups (Table 2 ; P<0.001). A Student-Newmanmention of a symptom' between baseline and follow-up. The diCerent treatments had clearly diCerent impacts on Keuls test, maintaining a 5% experiment-wise significance level, indicated that the diCerences were statistisymptoms, with the surgical treatments (TURP, 'other' and minimally invasive therapies) having the greatest cally significant only between surgical (particularly TURP and other treatments) and more conservative impact, and drugs and watchful waiting the least. The picture was similar for the problems caused; probtreatments (drug and minimally invasive therapies, and watchful waiting). lems relating to 10 LUTS (nocturia, urgency, hesitancy, strain to start, strain to continue, reduced stream, inter- Table 2 also shows the diCerences in treatments by countries in Phase II of the study. The treatments mittency, incomplete emptying, terminal dribble and frequency) were statistically significantly better at follow-up received were statistically significantly diCerent between countries, with patients in Italy, Denmark, Australia, than baseline for those undergoing TURP (P<0.0025; Fig. 1 ). For 'other treatments', four LUTS were statistically Japan and the UK tending to undergo surgical treatments, and patients from the Netherlands, Portugal, significantly better (frequency, nocturia, urgency and terminal dribble, P<0.0025). With minimally invasive Israel and Germany having more conservative treatments (an extension of the Fisher's exact test, therapies, problems related only to intermittency were statistically significantly better (P<0.0025). With drugs, P<0.0001). Table 2 also shows the age distributions within treatment groups; although older men were more only problems associated with frequency and nocturia reached this level of significance, and again the watchful likely to undergo TURP, diCerences between groups were not statistically significant (anova, P=0.14).
waiting group remained stable (Table 3) . between the treatment groups in terms of age and symptom levels. There were no statistically significant MIT, Minimally invasive treatment.
diCerences in age among the treatment groups. Symptom levels were similar for those undergoing TURP or minimally invasive therapies, and were also similar for those Discussion receiving drug therapies and watchful waiting. However, as would be expected, men who underwent surgical, These results suggest that the ICSmale questionnaire is sensitive to expected changes after interventions. The 'other' and minimally invasive treatments had, on the whole, higher levels of symptoms than those who changes were most apparent and significant for patients who underwent TURP, where most LUTS (15 in all) were received more conservative therapies (drugs and watchful waiting). very significantly better at follow-up than at baseline (P<0.0001). Those who received drug therapies, five
It was possible only to follow a proportion of patients recruited to Phase I of the ICS-'BPH' study in Phase II. LUTS were highly significantly better, with five more significantly so; those receiving 'other' therapies also had Centres were requested to follow-up as many patients as possible, but it is evident from Table 1 that the completeimprovements at follow-up. For minimally invasive therapies, four LUTS were very significantly better at follow-up ness of the follow-up varied between centres. The patients followed were apparently similar to those who were not than baseline and two were significantly better. No LUTS were statistically significantly diCerent between baseline in terms of age distribution and levels of symptoms, but it remains a possibility that the ICSmale questionnaire and follow-up for those undergoing watchful waiting.
The patterns of symptom improvement are intriguing; may not have been responsive to the outcomes of patients who were not followed-up. after TURP, the greatest number and widest range of symptoms were significantly improved, including both Although there are several diCerences between countries and treatment groups at both baseline [16] and filling and voiding symptoms. There were no symptoms that were significantly improved by other treatments but follow-up, the strength of the significant improvements in symptoms between baseline and follow-up suggests not by TURP. There was some consistency in the symptoms that were significantly improved by all interventions that the ICSmale questionnaire is sensitive to changes after interventions. However, these findings will need to (i.e. anything other than watchful waiting), with nocturia, hesitancy, urgency, intermittency and reduced stream be confirmed by truly comparable patient groups in randomized controlled trials. significantly improved by all active interventions.
However, there were several symptoms which were In conclusion, the results show that, among patients who were followed, symptom and problem questions in improved only after TURP and one or two other treatments; e.g. frequency was significantly improved after the ICSmale questionnaire are sensitive to changes that might be expected after various treatments. Most LUTS any of the surgical treatments (TURP, minimally invasive 
